PHUNWARE INC (PHUN)

US71948P2092 - Common Stock

6.53  -0.92 (-12.35%)

Fundamental Rating

3

Overall PHUN gets a fundamental rating of 3 out of 10. We evaluated PHUN against 282 industry peers in the Software industry. PHUN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PHUN is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year PHUN has reported negative net income.
PHUN had a negative operating cash flow in the past year.
In the past 5 years PHUN always reported negative net income.
PHUN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PHUN has a worse Return On Assets (-203.38%) than 96.79% of its industry peers.
PHUN's Return On Equity of -332.97% is on the low side compared to the rest of the industry. PHUN is outperformed by 84.29% of its industry peers.
Industry RankSector Rank
ROA -203.38%
ROE -332.97%
ROIC N/A
ROA(3y)-310.42%
ROA(5y)-209.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 111.28%, PHUN belongs to the top of the industry, outperforming 99.64% of the companies in the same industry.
In the last couple of years the Gross Margin of PHUN has declined.
PHUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 111.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.32%
GM growth 5Y-10.8%

6

2. Health

2.1 Basic Checks

PHUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHUN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHUN has more shares outstanding
The debt/assets ratio for PHUN is higher compared to a year ago.

2.2 Solvency

PHUN has an Altman-Z score of -13.95. This is a bad value and indicates that PHUN is not financially healthy and even has some risk of bankruptcy.
PHUN has a Altman-Z score of -13.95. This is amonst the worse of the industry: PHUN underperforms 91.43% of its industry peers.
PHUN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.95
ROIC/WACCN/A
WACC11.04%

2.3 Liquidity

PHUN has a Current Ratio of 2.82. This indicates that PHUN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PHUN (2.82) is better than 73.93% of its industry peers.
A Quick Ratio of 2.82 indicates that PHUN has no problem at all paying its short term obligations.
PHUN's Quick ratio of 2.82 is fine compared to the rest of the industry. PHUN outperforms 74.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 2.82

3

3. Growth

3.1 Past

The earnings per share for PHUN have decreased strongly by -38.52% in the last year.
The Revenue has grown by 312.18% in the past year. This is a very strong growth!
PHUN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -30.99% yearly.
EPS 1Y (TTM)-38.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.33%
Revenue 1Y (TTM)312.18%
Revenue growth 3Y-21.53%
Revenue growth 5Y-30.99%
Sales Q2Q%-71.01%

3.2 Future

PHUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.70% yearly.
PHUN is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -17.65% yearly.
EPS Next Y93.49%
EPS Next 2Y39.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-60.3%
Revenue Next 2Y-17.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PHUN. In the last year negative earnings were reported.
Also next year PHUN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PHUN's earnings are expected to grow with 39.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.7%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PHUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PHUNWARE INC

NASDAQ:PHUN (10/31/2024, 10:41:09 AM)

6.53

-0.92 (-12.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap74.05M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -203.38%
ROE -332.97%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 111.28%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.82
Quick Ratio 2.82
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-38.52%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y93.49%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)312.18%
Revenue growth 3Y-21.53%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y